Tasly’s 25-year quest to get the first complex Traditional Chinese Medicine approved by the FDA faces a setback as its U.S. partner walks away amid restructuring https://www.caixinglobal.com/2026-02-11/taslys-us-drug-push-falters-as-partner-ends-development-deal-102413420.html?rkey=4jojc%2BU9DvvtuaHc2n7nI%2FFL%2FE7ci4pKxCaXEyBJWzdf7%2FVU4dwNLQ%3D%3D&cxg=web&Sfrom=twitter